Acceptability of screening for HIV seroprevalence in women with cervical pathology

Mccarthy, Kathryn; Ma, Jun; Lawton, Frank; Studd, John

doi:10.1016/0140-6736(92)93056-s

Cited by 5 publications

(3 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In our population from an area of high HIV endemicity, HIV screening was accepted after counseling by approximately 50% of women. This acceptance of HIV screening is similar to the 60% and 67% acceptance rates noted in the previous smaller studies by McCarthy et al 12 and Spitzer et al, 13 respectively. Approximately 3% of our screened patients were identified as HIVinfected by voluntary screening.…”

Section: Discussionsupporting

confidence: 89%

Screening for Human Immunodeficiency Virus in Inner City Females With Abnormal Cervical Cytology

Jennings

Dottino

Sperling

et al. 1996

Infectious Diseases in Obstetrics and Gynecology

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 89%

Screening for Human Immunodeficiency Virus in Inner City Females With Abnormal Cervical Cytology

Jennings

Dottino

Sperling

et al. 1996

Infectious Diseases in Obstetrics and Gynecology

View full text Add to dashboard Cite

“…This acceptance of HIV screening is similar to the 60% and 67% acceptance rates noted in the previous smaller studies by McCarthy et al 12 and Spitzer et al, 13 respectively. In our population from an area of high HIV endemicity, HIV screening was accepted after counseling by approximately 50% of women.…”

Section: Discussionsupporting

confidence: 89%

Screening for human immunodeficiency virus in inner city females with abnormal cervical cytology

Jennings

Dottino

Sperling

et al. 1996

Infect. Dis. Obstet. Gynecol.

View full text Add to dashboard Cite

Objective This report evaluates the acceptance, results, and predictors of human immunodeficiency virus (HIV) infection in inner city women referred to a colposcopy clinic for abnormal cervical cytology. Methods HIV testing results of 1,908 inner city women referred for abnormal cervical cytology were analyzed retrospectively with respect to acceptance, race, ethnicity, Pap smear results, sexually transmitted diseases (STDs), HIV exposures, and final histologic findings. Results HIV testing was accepted by 50.4% of patients. Women who agreed to screening were significantly more likely to admit exposure to HIV or to be Hispanic, foreign‐born, or have a history of multiple STDs. Of those screened, 3.3% were found to be HIV seropositive. Although higher grades of referral Pap smears were noted in the women found to be HIV seropositive, final histologic findings were not different. The only predictors of unknown HIV seropositivity were admitted HIV exposure and external condyloma. Conclusions Fifty percent of inner city women of unknown HIV status referred for abnormal cervical cytology will accept HIV serotesting and 3.3% are found to be positive. Most HIV‐seropositive women can be detected based on either a history of exposure to HIV or the presence of external condyloma. Infect. Dis. Obstet. Gynecol. 4:281–286, 1996. © 1997 Wiley‐Liss, Inc.

show abstract

“…Prior to the availability of effective treatment in the form of highly active antiretroviral therapy, acceptance rates of HIV testing were found to be 50–60% 6 7. Data from New York showed HIV seroprevalence in colposcopy clinics was higher than in both antenatal clinics and the general population: 4% overall prevalence of undiagnosed HIV (6.1% in those accepting a test) compared with an estimated 1.24% of women of childbearing age and 1.6% of obstetric patients 8.…”

Section: Discussionmentioning

confidence: 99%

HIV testing in colposcopy and termination of pregnancy services: a missed opportunity?

Briggs

Partridge

Bates

2011

J Fam Plann Reprod Health Care

View full text Add to dashboard Cite

IntroductionThe 2008 National HIV testing guidelines produced jointly by the British Association of Sexual Health and HIV, British HIV Association and British Infection Society recommend HIV testing for patients attending termination of pregnancy (TOP) services and patients diagnosed with cervical intraepithelial neoplasia (CIN) Grade 2 or above. The aim is to reduce the time between acquisition and diagnosis of HIV by encouraging testing in settings where patients present with indicator diseases. Benefits of earlier HIV diagnosis include improved survival, prevention of onward transmission, and optimisation of maternal health when planning pregnancy. There is evidence that HIV reduces the effectiveness of standard treatment for CIN 2/3 and cervical cancer. The experience of antenatal screening indicates that the majority of women accept HIV screening if it is offered as part of a package of care.MethodsThis retrospective case notes review of 60 HIV-positive women, diagnosed between 1 January 2006 and 31 July 2009, collected data on age, ethnicity, length of time in the UK, timing of HIV diagnosis and possible timing of acquisition relative to attendance at colposcopy or TOP services, CD4 count and symptoms at diagnosis and cervical cytology history.ResultsThe authors found that three (5%) women were diagnosed with CIN Grade 2 or above prior to HIV diagnosis; HIV testing at the time of TOP may have resulted in earlier diagnosis for three (5%) women. There was at least one missed opportunity for earlier diagnosis in five (8%) cases.ConclusionsThe authors suggest further work should be undertaken to establish HIV prevalence in TOP and colposcopy services and that HIV testing should become standard practice in the management of CIN 2/3 and cervical cancer.

show abstract

Acceptability of screening for HIV seroprevalence in women with cervical pathology

Cited by 5 publications

References 3 publications

Screening for Human Immunodeficiency Virus in Inner City Females With Abnormal Cervical Cytology

Screening for Human Immunodeficiency Virus in Inner City Females With Abnormal Cervical Cytology

Screening for human immunodeficiency virus in inner city females with abnormal cervical cytology

HIV testing in colposcopy and termination of pregnancy services: a missed opportunity?

Contact Info

Product

Resources

About